
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Endocrinology
Study Phase : Preclinical
Sponsor : Breakthrough T1D
Deal Size : Undisclosed
Deal Type : Funding
Breakthrough T1D and Integrated Nano Partner To Develop T1D Therapy
Details : The company will advance INT's technology which employs multi-cargo LNP to deliver multiple antigens using mRNA, along with immune-modifying small molecules, to re-train the immune system in T1D.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
September 09, 2024
Lead Product(s) : Undisclosed
Therapeutic Area : Endocrinology
Highest Development Status : Preclinical
Sponsor : Breakthrough T1D
Deal Size : Undisclosed
Deal Type : Funding
